XML 56 R33.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Accounts Payable and Accrued Liabilities (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Payables and Accruals [Abstract] |
Schedule of Accounts Payable and Accrued Liabilities | Accounts payable and accrued liabilities consist of the following (in thousands):
| As of
| June 30, 2024 |  | December 31, 2023
Accounts payable and other accrued operating expenses | $ | 51,363 |  |  | $ | 65,393 |
Accrued clinical trial expenses | 22,581 |  |  | 23,711 |
Accrued professional fees | 16,114 |  |  | 13,885 |
Accrued technical operation expenses | 11,097 |  |  | 9,187 |
Accrued compensation and employee related costs | 42,198 |  |  | 48,933 |
Accrued royalty and milestones payable | 7,288 |  |  | 5,674 |
Accrued interest payable | 2,175 |  |  | 2,175 |
Revenue Interest Payments payable | 3,613 |  |  | 3,347 |
Accrued sales allowances and related costs | 14,479 |  |  | 10,937 |
Accrued France ATU reimbursement payable | 17,188 |  |  | 14,685 |
Deferred and contingent consideration | 81,600 |  |  | 6,700 |
Accrued milestone payment to AstraZeneca | 12,500 |  |  | — |
Other accrued liabilities | 8,648 |  |  | 10,360 |
| $ | 290,844 |  |  | $ | 214,987 |

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration